Evidence map›Paper›PMID 36178500›Full record

ArticleRheumatology international2023

How to optimize recruitment strategies of patients with rheumatic and musculoskeletal diseases for online surveys: experience from an international study.

Ihsane Hmamouchi, Antonella Abi Najm, Lina El Kibbi, Mona Metawee, Hussein Halabi, Nizar Abdulateef, Mervat Eissa, Manal El Rakawi, Basel Masri, Fatma Boutaiban and 5 more

Abstract read
In one paragraph

Article in Rheumatology international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Ihsane HmamouchiLaboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Mohammed V University, Rabat, BP 10000, Rabat, Morocco. ihsane.hmamouchi@gmail.com.ORCID 0000-0003-4402-5034
Antonella Abi NajmFaculty of Medicine, Saint-Joseph University, Beirut, Lebanon.
Lina El KibbiDivision of Rheumatology, Department of Internal Medicine, Specialized Medical Center, Riyadh, Saudi Arabia.ORCID 0000-0003-1710-9996
Mona MetaweeDivision of Rheumatology, Department of Internal Medicine, Specialized Medical Center, Riyadh, Saudi Arabia.ORCID 0000-0003-1764-4665
Hussein HalabiKing Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.ORCID 0000-0002-5174-8292
Nizar AbdulateefRheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.ORCID 0000-0003-0659-8130
Mervat EissaRheumatology Department, Cairo University, Cairo, Egypt.ORCID 0000-0001-7999-3401
Manal El RakawiRheumatology Department, Faculty of Medicine, Douera Hospital, Saad Dahlab, Blida, Algeria.ORCID 0000-0002-8235-4595
Basel MasriJordan Hospital, Amman, Jordan.ORCID 0000-0002-4592-1247
Fatma BoutaibanRheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah Hospital, Kuwait City, Kuwait.ORCID 0000-0002-6725-4561
Wafa HamdiRheumatology Department, Kassab Institute of Orthopedics, UR17SP04, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.ORCID 0000-0003-3045-4831
Asal AdnanRheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.ORCID 0000-0001-9140-5860
Renaud Felten *Department of Rheumatology, French National Reference Center for Autoimmune Diseases (CRMR RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID 0000-0002-4951-4032
Laurent Arnaud *Department of Rheumatology, French National Reference Center for Autoimmune Diseases (CRMR RESO), Hôpitaux Universitaires de Strasbourg, Strasbourg, France.ORCID 0000-0002-8077-8394
Nelly ZiadéRheumatology Department, Saint-Joseph Medical University and Hotel-Dieu de France Hospital, Beirut, Lebanon.ORCID 0000-0002-4479-7678

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of online surveys as a recruitment tool for clinical research has recently expanded; nevertheless, optimal recruitment strategies remain poorly identified. Objectives. The study aimed to identify the most effective recruitment strategies for online research studies and to determine the optimal survey channels for obtaining patients' responses. This is a post-hoc analysis of the ARCOVAX (ArLAR COVID Vaccination) study. Multiple recruitment strategies were disseminated in Arabic, English, and French. The proportion of enrolled patients was correlated with each strategy. Channels used by patients to complete the survey were divided into three categories (social media (SoMe), doctor, and patients' associations). These channels were correlated with the patients' characteristics and the country's Gross Domestic Product (GDP). A total of 1595 patients from 19 Arab countries completed the survey. Patients' mean age was 39 years, 73.2% (1159) were females, 17.8% (284) had a university education level and 93.1% (1468) answered the survey in Arabic. The most effective recruitment strategies were personalized WhatsApp reminders to recruiters (30% of enrolled patients), technical support in response to access issues (27%) and sharing recruitment status by country on a WhatsApp group (24%). The channels used to complete the survey were: SoMe in 45% (711), doctor in 40% (647), and patients' associations in 8.5% (233), and correlated with age and GDP. To optimize recruitment, it is recommended to combine multiple strategies and channels, use the native language and be active (mobilize teams), reactive (provide prompt technical support), and proactive (share regular updates and reminders).

Indexed as

COVID-19Musculoskeletal DiseasesSocial MediaAdultFemaleHumansMaleSurveys and QuestionnairesVaccinationClinical researchOnline surveyRecruitment strategiesRheumatic diseasesSocial media

Identifiers

PMID36178500
PMCPMC9523174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.